On the public citation graph

Fragment-Based Screening of the Bromodomain of ATAD2

0 signed · 100 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10858-013-9740-zopenalex-snapshot
Fragment-based drug discovery using NMR spectroscopy
inferredcites →https://doi.org/10.1016/j.cell.2012.02.013openalex-snapshot
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
inferredcites →https://doi.org/10.1021/cb500072zopenalex-snapshot
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
inferredcites →https://doi.org/10.1021/jm049131ropenalex-snapshot
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
inferredcites →https://doi.org/10.1021/jm300346wopenalex-snapshot
Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
inferredcites →https://doi.org/10.1021/jm401582copenalex-snapshot
Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
inferredcites →https://doi.org/10.1038/nrd4286openalex-snapshot
Targeting bromodomains: epigenetic readers of lysine acetylation
inferredcites →https://doi.org/10.1038/onc.2010.259openalex-snapshot
Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers
inferredcites →https://doi.org/10.1039/c4md00237gopenalex-snapshot
Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
inferredcites →https://doi.org/10.1073/pnas.0705814104openalex-snapshot
ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERα, is required for coregulator occupancy and chromatin modification
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.1126/science.278.5337.497openalex-snapshot
Discovering High-Affinity Ligands for Proteins
inferredcites →https://doi.org/10.1128/mcb.00484-10openalex-snapshot
Chromatin Loading of E2F-MLL Complex by Cancer-Associated Coregulator ANCCA via Reading a Specific Histone Mark
inferredcites →https://doi.org/10.1158/0008-5472.can-08-3440openalex-snapshot
Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-09-2131openalex-snapshot
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
inferredcites →https://doi.org/10.1158/0008-5472.can-10-1199openalex-snapshot
ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2
inferredcites →https://doi.org/10.1158/1541-7786.mcr-09-0095openalex-snapshot
Deregulated E2F and the AAA+ Coregulator ANCCA Drive Proto-Oncogene ACTR/AIB1 Overexpression in Breast Cancer
inferredcites →https://doi.org/10.1186/1475-2867-14-33openalex-snapshot
Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4793658openalex-extracted
Alternative Synthetic Route for the Pharmacophore of Atad2 Inhibitors: Triazolopyridazine Derivative
inferred← citeshttps://doi.org/10.1002/9783527683604.ch15openalex-snapshot
Epigenetics and Fragment‐Based Drug Discovery
inferred← citeshttps://doi.org/10.1002/ange.201411658openalex-snapshot
Fragment Screening and Druggability Assessment for the CBP/p300 KIX Domain through Protein‐Observed 19F NMR Spectroscopy
inferred← citeshttps://doi.org/10.1002/ange.201511351openalex-snapshot
Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9
inferred← citeshttps://doi.org/10.1002/ange.201812164openalex-snapshot
Chemische Epigenetik: der Einfluss chemischer und chemo‐biologischer Techniken auf die Zielstruktur‐Validierung von Bromodomänen
inferred← citeshttps://doi.org/10.1002/anie.201411658openalex-snapshot
Fragment Screening and Druggability Assessment for the CBP/p300 KIX Domain through Protein‐Observed 19F NMR Spectroscopy
inferred← citeshttps://doi.org/10.1002/anie.201511351openalex-snapshot
Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9
inferred← citeshttps://doi.org/10.1002/anie.201812164openalex-snapshot
Chemical Epigenetics: The Impact of Chemical and Chemical Biology Techniques on Bromodomain Target Validation
inferred← citeshttps://doi.org/10.1002/cbic.201600184openalex-snapshot
NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains
inferred← citeshttps://doi.org/10.1002/cbic.202000787openalex-snapshot
Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class
inferred← citeshttps://doi.org/10.1002/cbic.70443openalex-snapshot
Eyes Toward the Clinic: Selective Inhibition and Degradation Approaches to Bromodomain‐Containing Proteins
inferred← citeshttps://doi.org/10.1002/chem.201704169openalex-snapshot
Synthesis and Demonstration of the Biological Relevance of sp3‐rich Scaffolds Distantly Related to Natural Product Frameworks
inferred← citeshttps://doi.org/10.1002/cmdc.201500141openalex-snapshot
Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif
inferred← citeshttps://doi.org/10.1002/cmdc.201500540openalex-snapshot
Progress in the Development of non‐BET Bromodomain Chemical Probes
inferred← citeshttps://doi.org/10.1002/jcp.28545openalex-snapshot
Overexpression of microRNA‐186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2
inferred← citeshttps://doi.org/10.1002/med.21942openalex-snapshot
Recent progress and structural analyses of domain‐selective BET inhibitors
inferred← citeshttps://doi.org/10.1002/prot.25636openalex-snapshot
Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain
inferred← citeshttps://doi.org/10.1007/7355_2019_79openalex-snapshot
Applied Biophysics for Bromodomain Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-13-0773-7_6openalex-snapshot
Fragment-Based Drug Discovery for Developing Inhibitors of Protein-Protein Interactions
inferred← citeshttps://doi.org/10.1007/s00044-016-1686-8openalex-snapshot
Molecular docking and QSAR analysis of naphthyridone derivatives as ATAD2 bromodomain inhibitors: application of CoMFA, LS-SVM, and RBF neural network
inferred← citeshttps://doi.org/10.1007/s10858-020-00325-xopenalex-snapshot
Efficient affinity ranking of fluorinated ligands by 19F NMR: CSAR and FastCSAR
inferred← citeshttps://doi.org/10.1007/s12015-025-11029-wopenalex-snapshot
Bromodomain-Driven Regulation of Stem Cells: A Potential Target for Cancer Therapeutic Intervention
inferred← citeshttps://doi.org/10.1016/b978-0-12-802389-1.00005-8openalex-snapshot
The Bromodomain as an Acetyl-Lysine Reader Domain
inferred← citeshttps://doi.org/10.1016/b978-0-12-818655-8.00104-9openalex-snapshot
1,3-Thiazines and Their Benzo Derivatives
inferred← citeshttps://doi.org/10.1016/bs.mie.2015.05.013openalex-snapshot
Isotope Labeling of Proteins in Insect Cells
inferred← citeshttps://doi.org/10.1016/j.bbagen.2016.10.003openalex-snapshot
NMR characterization of weak interactions between RhoGDI2 and fragment screening hits
inferred← citeshttps://doi.org/10.1016/j.bcp.2015.12.005openalex-snapshot
Bromodomains: Structure, function and pharmacology of inhibition
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.04.089openalex-snapshot
Progress in discovery of small-molecule modulators of protein–protein interactions via fragment screening
inferred← citeshttps://doi.org/10.1016/j.ddtec.2016.06.005openalex-snapshot
Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113446openalex-snapshot
AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119322openalex-snapshot
Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives
inferred← citeshttps://doi.org/10.1016/j.tetlet.2024.155193openalex-snapshot
Alternative synthetic route for the pharmacophore of anticancer agent: Triazolopyridazine derivative
inferred← citeshttps://doi.org/10.1021/acs.accounts.9b00377openalex-snapshot
SAR by (Protein-Observed) 19F NMR
inferred← citeshttps://doi.org/10.1021/acs.chemrev.4c00892openalex-snapshot
Drugging Challenging Cancer Targets Using Fragment-Based Methods
inferred← citeshttps://doi.org/10.1021/acs.chemrev.5b00205openalex-snapshot
Discovery of Chemical Inhibitors of Human Bromodomains
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01610openalex-snapshot
Accounting for Solvation Correlation Effects on the Thermodynamics of Water Networks in Protein Cavities
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c01681openalex-snapshot
Thermal Titration Molecular Dynamics: The Revenge of the Fragments
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00787openalex-snapshot
From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD)
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c01871openalex-snapshot
Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01861openalex-snapshot
Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00256openalex-snapshot
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00405openalex-snapshot
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b00772openalex-snapshot
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01514openalex-snapshot
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00012openalex-snapshot
Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00215openalex-snapshot
Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00862openalex-snapshot
Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00673openalex-snapshot
A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification
inferred← citeshttps://doi.org/10.1021/acs.jpcb.5c05744openalex-snapshot
From MM-PBSA to H-MMGB: Multiscale Modeling for Biomolecular Structure and Drug Discovery
inferred← citeshttps://doi.org/10.1021/acschembio.0c00720openalex-snapshot
Quantifying the Selectivity of Protein–Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins
inferred← citeshttps://doi.org/10.1021/acschembio.5b00483openalex-snapshot
Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules
inferred← citeshttps://doi.org/10.1021/acschembio.5b00831openalex-snapshot
The Bromodomain: A New Target in Emerging Epigenetic Medicine
inferred← citeshttps://doi.org/10.1021/acschembio.5b00914openalex-snapshot
High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography
inferred← citeshttps://doi.org/10.1021/acschembio.6b00730openalex-snapshot
Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR
inferred← citeshttps://doi.org/10.1021/acschembio.7b00708openalex-snapshot
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.2c00429openalex-snapshot
Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
inferred← citeshttps://doi.org/10.1021/jm501893kopenalex-snapshot
9 H -Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
inferred← citeshttps://doi.org/10.1038/aps.2017.188openalex-snapshot
Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay
inferred← citeshttps://doi.org/10.1038/s41573-019-0030-7openalex-snapshot
Bromodomains: a new target class for drug development
inferred← citeshttps://doi.org/10.1038/s41594-019-0309-8openalex-snapshot
Bromodomain biology and drug discovery
inferred← citeshttps://doi.org/10.1038/s42004-018-0019-xopenalex-snapshot
Large-scale analysis of water stability in bromodomain binding pockets with grand canonical Monte Carlo
inferred← citeshttps://doi.org/10.1039/9781788016544-00209openalex-snapshot
Pharmacological Regulation and Functional Significance of Chromatin Binding by BET Tandem Bromodomains
inferred← citeshttps://doi.org/10.1039/c5md00209eopenalex-snapshot
Fragments in bromodomain drug discovery
inferred← citeshttps://doi.org/10.1039/c6ra21226copenalex-snapshot
Paramagnetic relaxation enhancement for protein-observed 19 F NMR as an enabling approach for efficient fragment screening
inferred← citeshttps://doi.org/10.1039/c8ob00099aopenalex-snapshot
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
inferred← citeshttps://doi.org/10.1042/bj20140933openalex-snapshot
Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2
inferred← citeshttps://doi.org/10.1073/pnas.1917814117openalex-snapshot
The ATAD2/ANCCA homolog Yta7 cooperates with Scm3 HJURP to deposit Cse4 CENP-A at the centromere in yeast
inferred← citeshttps://doi.org/10.1074/jbc.m117.786350openalex-snapshot
The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes
inferred← citeshttps://doi.org/10.1080/1062936x.2017.1385532openalex-snapshot
The identification of new ATAD2 bromodomain inhibitors: the application of combined ligand and structure-based virtual screening
inferred← citeshttps://doi.org/10.1080/14728222.2018.1406921openalex-snapshot
ATAD2 in cancer: a pharmacologically challenging but tractable target
inferred← citeshttps://doi.org/10.1080/14756366.2020.1740924openalex-snapshot
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
inferred← citeshttps://doi.org/10.1080/14756366.2023.2242601openalex-snapshot
Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells
inferred← citeshttps://doi.org/10.1093/jjco/hyv195openalex-snapshot
ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000017180openalex-snapshot
Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers
inferred← citeshttps://doi.org/10.15406/mojbb.2017.04.00062openalex-snapshot
Using Fragment Based Drug Discovery to Target Epigenetic Regulators in Cancer
inferred← citeshttps://doi.org/10.2174/2666001602666220516093452openalex-snapshot
Hologram QSAR and Topomer CoMFA Study on Naphthyridone Derivatives as ATAD2 Bromodomain Inhibitors
inferred← citeshttps://doi.org/10.3390/cancers17203337openalex-snapshot
ATAD2 as a Cancer Target: Insights into Its Structure, Functions, Mechanisms, and Drug Development
inferred← citeshttps://doi.org/10.3390/molecules21070854openalex-snapshot
Process of Fragment-Based Lead Discovery—A Perspective from NMR
inferred← citeshttps://doi.org/10.3390/molecules25173949openalex-snapshot
Combined Protein- and Ligand-Observed NMR Workflow to Screen Fragment Cocktails against Multiple Proteins: A Case Study Using Bromodomains
inferred← citeshttps://doi.org/10.4155/fmc-2016-0059openalex-snapshot
Selectivity On-Target of Bromodomain Chemical Probes by Structure-Guided Medicinal Chemistry and Chemical Biology
inferred← citeshttps://doi.org/10.4155/fmc-2020-0294openalex-snapshot
Abiotic Scaffolds in Medicinal Chemistry: Not a Waste of Chemical Space
inferred← citeshttps://doi.org/10.7150/thno.78840openalex-snapshot
ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.